The Scientist

» hair-follicle stem cells

Most Recent

image: More Than Skin Deep

More Than Skin Deep

By | May 1, 2016

Elaine Fuchs has worked on adult stem cells since before they were so named, figuring out how multipotent epidermal cells renew or turn into skin or hair follicles.

1 Comment

image: Stem Cells to Blame for Hair Loss?

Stem Cells to Blame for Hair Loss?

By | February 8, 2016

Two new studies point to factors in hair follicle stem cells as players in age-related hair loss.

0 Comments

image: Spotlight on Stem Cells

Spotlight on Stem Cells

By | December 16, 2013

Elaine Fuchs and Craig Venter touted the promise of stem cell research at the American Society for Cell Biology annual meeting.

0 Comments

image: A Hair-Raising Solution?

A Hair-Raising Solution?

By | September 1, 2013

In the long-fought battle against baldness, researchers are finally identifying molecular pathways that can be manipulated to generate new hair follicles.

1 Comment

image: Master of Fate

Master of Fate

By | July 1, 2013

While tracing the tricky and sometimes surprising paths of multipotent cells in the skin, mammary gland, and heart, Cédric Blanpain has repeatedly turned the stem cell field on its head.  

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham